Immediate Impact
53 standout
Citing Papers
Cystic fibrosis
2024 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Works of Barry Clements being referenced
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial
2022
Role of Tris-CaEDTA as an adjuvant with nebulised tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa lung infections: A randomised controlled trial
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Barry Clements | 399 | 278 | 84 | 22 | 601 | |
| Oppenheimer Eh | 357 | 219 | 87 | 26 | 667 | |
| Peter H. Michelson | 277 | 166 | 115 | 18 | 617 | |
| L. Mared | 227 | 439 | 53 | 21 | 691 | |
| M. I. Bultitude | 212 | 141 | 149 | 20 | 626 | |
| Steven Strausbaugh | 222 | 141 | 43 | 23 | 688 | |
| Esterly | 311 | 160 | 50 | 25 | 521 | |
| Adèle Coriati | 448 | 225 | 25 | 39 | 661 | |
| Diana Costantini | 541 | 147 | 115 | 17 | 668 | |
| R. Nové-Josserand | 317 | 84 | 111 | 33 | 577 | |
| Phuong-Thu Pham | 107 | 295 | 62 | 22 | 674 |
All Works
Login with ORCID to disown or claim papers
Loading papers...